Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes (Q44695536)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2013
edit
Language Label Description Also known as
English
Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes
scientific article published in May 2013

    Statements

    Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit